Skip to content
Subscriber Only

Pfizer Backed Down From Demand That Was ‘Risk’ to S. Africa

  • Company sought sole right to determine indemnity guarantee
  • Dispute has delayed the delivery of Pfizer’s vaccines
Updated on

Deliveries of Pfizer Inc.’s Covid-19 vaccine to South Africa were delayed by demands from the U.S. drugmaker that it determine the guarantees needed to indemnify the company from any negative effects from the shots.

The condition was resisted by the government and Pfizer eventually backed down, agreeing to supply 30 million doses of the vaccine co-developed with Germany’s BioNTech SE.